Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v7-EN
Language English English
Date Updated 2021-05-15 2021-05-15
Drug Identification Number 00028096 00028096
Brand name CELESTONE SOLUSPAN CELESTONE SOLUSPAN
Common or Proper name BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID
Company Name ORGANON CANADA INC. ORGANON CANADA INC.
Ingredients BETAMETHASONE ACETATE BETAMETHASONE BETAMETHASONE ACETATE BETAMETHASONE
Strength(s) 3MG 3MG 3MG 3MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRA-ARTICULAR INTRABURSAL INTRADERMAL INTRAMUSCULAR INTRA-ARTICULAR INTRABURSAL INTRADERMAL INTRAMUSCULAR INTRA-ARTICULAR INTRABURSAL INTRADERMAL INTRAMUSCULAR INTRA-ARTICULAR INTRABURSAL INTRADERMAL INTRAMUSCULAR
Packaging size 5ML 5ML
ATC code H02AB H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2021-05-04 2021-05-04
Actual start date 2021-05-04 2021-05-04
Estimated end date 2021-05-14 2021-05-14
Actual end date 2021-05-14 2021-05-14
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments